Evidence map›Paper›PMID 23825067›Full record

ArticleAmerican journal of physiology. Renal physiology2013

Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats.

Aaron J Polichnowski, Karen A Griffin, Jianrui Long, Geoffrey A Williamson, Anil K Bidani

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Impact ofMicroorganisms · 2021
    Review
  4. Article
  5. Review
  6. Role of Rho in Salt-Sensitive Hypertension.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Renal autoregulation in health and disease.Physiological reviews · 2015
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aaron J PolichnowskiCorrespondence: A. K. Bidani, Loyola Univ. Medical Center, 2160 South First Ave., Maywood, IL 60153. abidani@lumc.edu.
Karen A Griffin
Jianrui Long
Geoffrey A Williamson
Anil K Bidani
Loyola Medicine · USIllinois Institute of Technology · US

Funding

PATHOLOGY OF HYPERTENSIVE INJURY IN REMNANT KIDNEYSR01DK040426 · NIDDK · RUSH UNIVERSITY MEDICAL CENTER · PI BIDANI, ANIL K · 1990 to 2011
$2.8M
Dynamic BP load and diabetic nephropathy phenotype.R01DK061653 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI GRIFFIN, KAREN A. · 2002 to 2014
$2.1M
NIDDK NIH HHS DK-40426NIDDK NIH HHS DK-61653
6 · The paper itself

Abstract

Chronic ANG II infusion in rodents is widely used as an experimental model of hypertension, yet very limited data are available describing the resulting blood pressure-renal blood flow (BP-RBF) relationships in conscious rats. Accordingly, male Sprague-Dawley rats (n = 19) were instrumented for chronic measurements of BP (radiotelemetry) and RBF (Transonic Systems, Ithaca, NY). One week later, two or three separate 2-h recordings of BP and RBF were obtained in conscious rats at 24-h intervals, in addition to separate 24-h BP recordings. Rats were then administered either ANG II (n = 11, 125 ng·kg(-1)·min(-1)) or phenylephrine (PE; n = 8, 50 mg·kg(-1)·day(-1)) as a control, ANG II-independent, pressor agent. Three days later the BP-RBF and 24-h BP recordings were repeated over several days. Despite similar increases in BP, PE led to significantly greater BP lability at the heart beat and very low frequency bandwidths. Conversely, ANG II, but not PE, caused significant renal vasoconstriction (a 62% increase in renal vascular resistance and a 21% decrease in RBF) and increased variability in BP-RBF relationships. Transfer function analysis of BP (input) and RBF (output) were consistent with a significant potentiation of the renal myogenic mechanism during ANG II administration, likely contributing, in part, to the exaggerated reductions in RBF during periods of BP elevations. We conclude that relatively equipressor doses of ANG II and PE lead to greatly different ambient BP profiles and effects on the renal vasculature when assessed in conscious rats. These data may have important implications regarding the pathogenesis of hypertension-induced injury in these models of hypertension.

Indexed as

Disease Models, AnimalAngiotensin IIAnimalsBlood PressureConsciousnessHeart RateHemodynamicsHypertensionInfusions, IntravenousMalePhenylephrineRatsRats, Sprague-DawleyRenal CirculationTelemetryVasoconstrictor AgentsAngiotensin IIPhenylephrineVasoconstrictor Agentsblood pressure variabilityhemodynamicshypertension

Identifiers

PMID23825067
PMCPMC3798740
OpenAlexW2031095936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.